Project Number 5P01AG060882-03 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Blocking the binding of Aβ and apoE as a novel therapeutic approach for AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology Category F. Research Resources 2. Other Types of Cores or Centers Researcher and Organization Principal Investigator WISNIEWSKI, THOMAS M Principal Investigator First Name THOMAS M Principal Investigator Last Name WISNIEWSKI Awardee Organization NEW YORK UNIVERSITY SCHOOL OF MEDICINE Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-18-297: NIA Program Project Applications (P01 Clinical Trial Optional) FY Overall Cost $620,426 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official YANG, AUSTIN JYAN-YU
